Brief: Havencrest Healthcare Partners Reports Stake Of 12.04% In Oncology Institute As Of Dec 28, 2023
02/01/2024 23:22
Jan 2 (Reuters) - Oncology Institute Inc TOI.O :
* HAVENCREST HEALTHCARE PARTNERS GP, LLC REPORTS STAKE OF
12.04%
IN ONCOLOGY INSTITUTE AS OF DEC 28, 2023 VERSUS. PREVIOUS STAKE
OF 18.9% AS OF NOV 3, 2022
Further company coverage: TOI.O
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million